Clinical Significance of Plasma and Serum Vascular Endothelial Growth Factor in Asthma

Background. Vascular endothelial growth factor (VEGF) is a mediator of airway inflammation and remodeling in asthma. Purpose. We investigated whether VEGF levels are elevated in plasma and serum obtained from patients with asthma and evaluated whether levels of plasma VEGF correlated with those of serum VEGF. Methods. We measured levels of plasma and serum VEGF in patients with stable asthma or with acute asthma and examined the correlation between plasma and serum VEGF concentration with initial forced expiratory volume in 1 second (FEV1). Results. We found that levels of VEGF in plasma or in serum were significantly increased in stable asthmatic patients and even higher in acute asthmatic patients compared with the levels in healthy control subjects. The levels of serum VEGF correlated significantly with those of plasma VEGF. Additionally, the circulating VEGF levels were significantly inversely correlated with the percent predicted FEV1. Conclusion. These results suggest that the overproduction of VEGF is implicated in asthma exacerbation and that measurement of either plasma or serum VEGF level can be a valid index in asthmatic patients. Therefore, the changes in the VEGF levels in peripheral blood of asthmatic patients can be used as a measure for progression of asthma during treatment.

[1]  G. Jin,et al.  Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma. , 2006, American journal of respiratory and critical care medicine.

[2]  G. Jin,et al.  Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression. , 2004, The Journal of allergy and clinical immunology.

[3]  R. Homer,et al.  Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung , 2004, Nature Medicine.

[4]  Megumi Baba,et al.  The significance of circulating vascular endothelial growth factor (VEGF) protein in gastric cancer. , 2003, Cancer letters.

[5]  Yong Chul Lee,et al.  Contribution of Vascular Endothelial Growth Factor to Airway Hyperresponsiveness and Inflammation in a Murine Model of Toluene Diisocyanate-Induced Asthma1 , 2002, The Journal of Immunology.

[6]  G Salvato,et al.  Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects , 2001, Thorax.

[7]  F. Thien,et al.  Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma. , 2001, American journal of respiratory and critical care medicine.

[8]  Yong Chul Lee,et al.  Vascular endothelial growth factor in patients with acute asthma. , 2001, The Journal of allergy and clinical immunology.

[9]  Q. Hamid,et al.  Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. , 2001, The Journal of allergy and clinical immunology.

[10]  E. Gunsilius,et al.  Correspondence re: M.L. George [correction of H.L. George] et al., Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin. Cancer Res., 6: 3147-3152, 2000. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  N. Aoike,et al.  Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. , 2001, The Journal of allergy and clinical immunology.

[12]  S. Fan,et al.  Serum Vascular Endothelial Growth Factor Predicts Venous Invasion in Hepatocellular Carcinoma : A Prospective Study , 2001, Annals of surgery.

[13]  A. Feldman,et al.  Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  S. Eccles,et al.  Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  R. Djukanović,et al.  Bronchial angiogenesis in severe glucocorticoid-dependent asthma. , 2000, The European respiratory journal.

[16]  T. Yoshikawa,et al.  Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma. , 2000, Cancer letters.

[17]  J Bousquet,et al.  Asthma. From bronchoconstriction to airways inflammation and remodeling. , 2000, American journal of respiratory and critical care medicine.

[18]  N. Glazer,et al.  Angiopoietin-1 protects the adult vasculature against plasma leakage , 2000, Nature Medicine.

[19]  G. Gastl,et al.  Thrombocytes Are the Major Source for Soluble Vascular Endothelial Growth Factor in Peripheral Blood , 2000, Oncology.

[20]  T. Allen-Mersh,et al.  Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver metastasis vascularity and volume , 2000, British Journal of Cancer.

[21]  F. Thien,et al.  Vascularity in asthmatic airways: relation to inhaled steroid dose. , 1999, Thorax.

[22]  P. Vermeulen,et al.  Blood platelets and serum VEGF in cancer patients , 1999, British Journal of Cancer.

[23]  J. Weyler,et al.  Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer , 1999, British Journal of Cancer.

[24]  I. Hyodo,et al.  Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer. , 1998, European journal of cancer.

[25]  H. Joensuu,et al.  High pre‐treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small‐cell lung cancer , 1998, International journal of cancer.

[26]  E. Ingham,et al.  Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. , 1998, British Journal of Cancer.

[27]  K. Tanikawa,et al.  Circulating Vascular Endothelial Growth Factor in Patients With Colorectal Cancer , 1998, American Journal of Gastroenterology.

[28]  H. Verheul,et al.  Platelet: transporter of vascular endothelial growth factor. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  N. Taichman,et al.  Human neutrophils secrete vascular endothelial growth factor , 1997, Journal of leukocyte biology.

[30]  J. Wilson,et al.  Increased vascularity of the bronchial mucosa in mild asthma. , 1997, American journal of respiratory and critical care medicine.

[31]  T. Horiuchi,et al.  Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. , 1997, American journal of respiratory cell and molecular biology.

[32]  N. Charan,et al.  Bronchial vascular congestion and angiogenesis. , 1997, The European respiratory journal.

[33]  C. Persson.  Epithelial cells: barrier functions and shedding-restitution mechanisms. , 1996, American journal of respiratory and critical care medicine.

[34]  M. Toi,et al.  Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[35]  Jesse B. Hall,et al.  The assessment and management of adults with status asthmaticus. , 1995, American journal of respiratory and critical care medicine.

[36]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. , 1995, The American journal of pathology.

[37]  P. Barnes,et al.  Inhaled glucocorticoids for asthma. , 1995, The New England journal of medicine.

[38]  Criscuolo Gr.  The genesis of peritumoral vasogenic brain edema and tumor cysts: a hypothetical role for tumor-derived vascular permeability factor. , 1993 .

[39]  T. Out,et al.  Respiratory membrane permeability and bronchial hyperreactivity in patients with stable asthma. Effects of therapy with inhaled steroids. , 1991, The American review of respiratory disease.

[40]  田村 昌也.  Plasma VEGF concentration can predict the tumor angiogenic capacity in non-small cell lung cancer , 2001 .

[41]  H. Sakahara,et al.  Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels. , 1997, British Journal of Cancer.

[42]  G. Criscuolo,et al.  The genesis of peritumoral vasogenic brain edema and tumor cysts: a hypothetical role for tumor-derived vascular permeability factor. , 1993, The Yale journal of biology and medicine.

[43]  Phillips Yy,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.